BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34804046)

  • 1. Siglecs Modulate Activities of Immune Cells Through Positive and Negative Regulation of ROS Generation.
    Karmakar J; Mukherjee K; Mandal C
    Front Immunol; 2021; 12():758588. PubMed ID: 34804046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania donovani Utilize Sialic Acids for Binding and Phagocytosis in the Macrophages through Selective Utilization of Siglecs and Impair the Innate Immune Arm.
    Roy S; Mandal C
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004904. PubMed ID: 27494323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialic acids siglec interaction: a unique strategy to circumvent innate immune response by pathogens.
    Khatua B; Roy S; Mandal C
    Indian J Med Res; 2013 Nov; 138(5):648-62. PubMed ID: 24434319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and expression of 3 siglecs-like in Oreochromis niloticus neutrophil, and their interaction with group B streptococcal sialylated capsular polysaccharides.
    Dong J; Wei Y; Ye X; Sun C; Tian Y; Lu M; Du J; Chen Z
    Mol Immunol; 2016 May; 73():158-69. PubMed ID: 26847490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Siglecs at the Host-Pathogen Interface.
    Chang YC; Nizet V
    Adv Exp Med Biol; 2020; 1204():197-214. PubMed ID: 32152948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interplay between Siglecs and sialylated pathogens.
    Chang YC; Nizet V
    Glycobiology; 2014 Sep; 24(9):818-25. PubMed ID: 24996821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment.
    van de Wall S; Santegoets KCM; van Houtum EJH; Büll C; Adema GJ
    Trends Immunol; 2020 Apr; 41(4):274-285. PubMed ID: 32139317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased erythrocyte binding of Siglec-9 increases neutrophil activation in sickle cell disease.
    Kiser ZM; Lizcano A; Nguyen J; Becker GL; Belcher JD; Varki AP; Vercellotti GM
    Blood Cells Mol Dis; 2020 Mar; 81():102399. PubMed ID: 31901888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The female reproductive tract contains multiple innate sialic acid-binding immunoglobulin-like lectins (Siglecs) that facilitate sperm survival.
    Tecle E; Reynoso HS; Wang R; Gagneux P
    J Biol Chem; 2019 Aug; 294(31):11910-11919. PubMed ID: 31201275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human sialoglycan ligands for immune inhibitory Siglecs.
    Gonzalez-Gil A; Li TA; Kim J; Schnaar RL
    Mol Aspects Med; 2023 Apr; 90():101110. PubMed ID: 35965135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sialoglycan-Siglec glyco-immune checkpoint - a target for improving innate and adaptive anti-cancer immunity.
    Bärenwaldt A; Läubli H
    Expert Opin Ther Targets; 2019 Oct; 23(10):839-853. PubMed ID: 31524529
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins.
    Linnartz-Gerlach B; Mathews M; Neumann H
    Neuroscience; 2014 Sep; 275():113-24. PubMed ID: 24924144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sialic acid-binding immunoglobulin-like lectin 8 (Siglec-8) is an activating receptor mediating β
    Carroll DJ; O'Sullivan JA; Nix DB; Cao Y; Tiemeyer M; Bochner BS
    J Allergy Clin Immunol; 2018 Jun; 141(6):2196-2207. PubMed ID: 28888781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of airway inflammation by Siglec-8 and Siglec-9 sialoglycan ligand expression.
    Schleimer RP; Schnaar RL; Bochner BS
    Curr Opin Allergy Clin Immunol; 2016 Feb; 16(1):24-30. PubMed ID: 26694037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid evolution of binding specificities and expression patterns of inhibitory CD33-related Siglecs in primates.
    Padler-Karavani V; Hurtado-Ziola N; Chang YC; Sonnenburg JL; Ronaghy A; Yu H; Verhagen A; Nizet V; Chen X; Varki N; Varki A; Angata T
    FASEB J; 2014 Mar; 28(3):1280-93. PubMed ID: 24308974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy approaches on innate immunity for SARS-Cov-2.
    Arslan BA; Timucin AC
    Acta Virol; 2020; 64(4):389-395. PubMed ID: 32985199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Siglecs as potential targets of therapy in human mast cell- and/or eosinophil-associated diseases.
    O'Sullivan JA; Youngblood BA; Schleimer RP; Bochner BS
    Semin Immunol; 2023 Sep; 69():101799. PubMed ID: 37413923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialic Acid-Siglec Axis in Human Immune Regulation, Involvement in Autoimmunity and Cancer and Potential Therapeutic Treatments.
    Gianchecchi E; Arena A; Fierabracci A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophil and mast cell Siglecs: From biology to drug target.
    O'Sullivan JA; Chang AT; Youngblood BA; Bochner BS
    J Leukoc Biol; 2020 Jul; 108(1):73-81. PubMed ID: 31965606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of siglecs and related glycan-binding proteins in immune responses and immunoregulation.
    Bochner BS; Zimmermann N
    J Allergy Clin Immunol; 2015 Mar; 135(3):598-608. PubMed ID: 25592986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.